Back to Funding Hub
Israel

Israel Innovation Authority Startup Fund 2026

Funding Amount
Pre-seed: 60% up to NIS 1.5M | Round A: 30% up to NIS 15M

Program Overview

The Israel Innovation Authority Startup Fund provides targeted non-dilutive R&D grants at different funding stages. As part of the government's transformative stimulus package, the fund injects over half a billion shekels annually into seed, pre-seed, and Series A rounds for startups with limited access to capital.

Grant Structure by Stage

Pre-Seed companies: 60% of investment round amount covered by grant, up to maximum of NIS 1.5 million total grant. Round A companies: 30% of investment round amount covered by grant, up to maximum of NIS 15 million total grant. Both stages: Non-dilutive funding with no equity or voting rights taken by Innovation Authority.

Non-Dilutive Structure

Critical advantage: Grants do not require equity dilution. Innovation Authority does not take board seats or voting rights. Funding comes as grants, not loans (no repayment required for R&D failure). Royalty-based repayment only upon commercial success. Preserves founder ownership and control.

Eligibility Requirements

Israeli-registered company conducting R&D in Israel. Pre-seed or Series A funding stage. Demonstrable innovation and technology development. Limited access to traditional capital sources. R&D plan aligned with Innovation Authority priorities. Strong technical team and viable commercialization path.

Application Process

Submit application through Innovation Authority portal (innovationisrael.org.il). Provide detailed R&D plan and budget. Demonstrate investment round status (pre-seed or Round A). Present technology innovation and market opportunity. Evaluation: Technical and commercial review by Authority committees. Processing: Typically 2-3 months from submission to decision.

2026 Government Stimulus Context

As part of the government's high-tech stimulus package: New startup fund injects NIS 500+ million annually. Second round of YOZMA Fund ($300M) launching Q1 2026. Total government commitment exceeding NIS 800 million. Strong signal of continued support for Israeli innovation ecosystem.

Strategic Advantages

Substantial grant coverage (60% pre-seed, 30% Round A). Non-dilutive (no equity given up). High maximum amounts (NIS 1.5M and 15M). Can combine with R&D tax credits. Credibility boost from Innovation Authority selection. Part of broader $500M+ annual innovation funding.

Contact Information

Israel Innovation Authority: innovationisrael.org.il/en | Startup Fund: innovationisrael.org.il/en/programs/startup-fund | Email: info@innovationisrael.org.il | Phone: +972-3-7144444

Common Questions

The Israel Innovation Authority (IIA) provides grants covering 20-50% of approved R&D project budgets for startups at various stages. The Startup Fund specifically targets pre-seed, seed, and early-stage companies with conditional grants that are repaid as royalties only if the product reaches commercial success. IIA grants allow startups to retain their intellectual property while receiving meaningful R&D funding.

If a product developed with IIA funding generates revenue, the company must pay royalties of 3-5% of sales until the grant amount is fully repaid, typically with interest linked to the LIBOR rate. If the product does not reach commercial success, the grant does not need to be repaid, effectively making it a conditional grant. This risk-sharing model is a distinctive feature of Israel's innovation support system.

The IIA provides conditional grants rather than equity, preserving founder ownership with royalty-based repayment triggers. Recipients pay royalties only upon generating commercial revenue from funded IP, as a percentage until the original amount is repaid. If qualifying revenue never materializes, no repayment is due. This asymmetric risk-sharing encourages ambitious exploration while enabling partial public resource recovery.

IP from IIA-funded projects must remain in Israel under the Encouragement of R&D Law unless committee approval is obtained. Transferring production abroad requires formal application and elevated royalty multiples compensating for lost economic benefits. These restrictions preserve the domestic industrial base and prevent arrangements where public funding subsidizes development later relocated without sustaining local employment.

Recipients must repay royalties calculated as three to five percent of commercial revenues from products developed using grant-funded technology until the inflation-adjusted amount is fully repaid. Obligations attach to the funded technology regardless of subsequent restructuring or acquisition. This conditional grant mechanism distinguishes Israel's approach from equity models, allowing founders to retain full ownership while sustaining the revolving innovation fund.

The Innovation Authority receives thousands of applications annually with approval rates typically ranging between twenty and forty percent. Evaluation committees of technology experts, industry veterans, and financial analysts assess proposals on innovation merit, market opportunity, team capability, and feasibility. Applicants demonstrating proof-of-concept results or private co-investment arrangements significantly improve positioning. Rejected applicants may resubmit revised proposals.

References

  1. Israel Innovation Authority Programs. Israel Innovation Authority (2025). View source
  2. Startup Division Programs. Israel Innovation Authority (2025). View source
  3. Israel Startup Ecosystem Report. Start-Up Nation Central (2024). View source

Ready to Explore AI Training in Israel?

We help organizations navigate funding programs and deliver claimable AI training. Let us know what you are working on.

Start a Conversation